PRAX

News Praxis down on trial setback for seizure therapy

8h ago

News Praxis (PRAX) Q2 Loss Widens 90%

14d ago

News Value Of Praxis Precision Medicines' Lead Program In Essential Tremor Alone Is Underappreciated: Analyst

14d ago

News Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?

14d ago

News JAZZ Falls as Suvecaltamide Tremor Study Fails to Meet Goals

14d ago

News Why Is Praxis Precision Stock Soaring Tuesday?

49d ago

News Praxis Precision gains as lead asset accepted for FDA review

49d ago

News Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline

81d ago

News Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings

81d ago

News Novo Nordisk Sued Over Alleged Scheme To Delay Generic Victoza In Favor Of Ozempic

123d ago

News Here’s Why Wall Street is Bullish on Flex Ltd. (FLEX)

125d ago

News Praxis Precision Medicines, Inc. (PRAX) a Strong Buy, Per Wall Street Consensus

138d ago

News Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments

144d ago

News Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering

146d ago

News Praxis Precision Medicines, Inc. Announces Proposed Public Offering

146d ago

News Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering

153d ago

News Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

154d ago

News Truist Securities reiterates Buy rating on Praxis Precision Medicines stock

154d ago